The global burden of osteoarthritis knee: a secondary data analysis of a population-based study.

IF 2.8 3区 医学 Q2 RHEUMATOLOGY Clinical Rheumatology Pub Date : 2025-04-01 Epub Date: 2025-02-12 DOI:10.1007/s10067-025-07347-6
Jia-Le Ren, Junnan Yang, Wan Hu
{"title":"The global burden of osteoarthritis knee: a secondary data analysis of a population-based study.","authors":"Jia-Le Ren, Junnan Yang, Wan Hu","doi":"10.1007/s10067-025-07347-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Osteoarthritis knee poses a substantial and pervasive global health challenge.</p><p><strong>Methods: </strong>The data was extracted from the Global Burden of Disease 2021 Study database. First, numbers and age-standardized rates (ASRs) of incidence, prevalence, and disability-adjusted life years (DALYs) of osteoarthritis knee were assessed globally and by sub-types in 2021. Subsequently, we employed a linear regression model to analyze the temporal trends from 1990 to 2021. To predict the future burden, we utilized the age-period-cohort model and the Bayesian age-period-cohort model. Furthermore, we conducted a sensitivity analysis using the Autoregressive Integrated Moving Average model and the Exponential Smoothing model.</p><p><strong>Results: </strong>In 2021, osteoarthritis knee accounted for 30.85 million incidence cases, 374.74 million prevalence cases, and 12.02 million DALYs cases globally, with ASRs of 353.67, 4294.27, and 137.59, respectively. Females and individuals over 50 years old were identified as high-risk populations, while higher socio-demographic index regions emerged as high-risk areas. From 1990 to 2021, incidence cases rose from 14.13 million to 30.85 million, prevalence cases from 159.80 million to 374.74 million, and DALYs cases from 5.15 million to 12.02 million, accompanied by increases in their respective ASRs. Projections using the APC model predict a continued increase in incidence, prevalence, and DALYs cases for both genders until 2046. Specifically, male incidence cases are projected to increase to 18.45 million and female incidence to 25.60 million. Similarly, male prevalence cases are projected to rise to 235.41 million and female prevalence to 365.97 million. Male DALYs cases are expected to increase to 7.52 million and female DALYs to 11.55 million. The BAPC models also indicate an upward trend in number of cases.</p><p><strong>Conclusion: </strong>In conclusion, osteoarthritis knee represents a formidable threat to global public health, necessitating the development of proactive and tailored strategic interventions that account for global-specific contexts. Key Points • Females and individuals over 50 years old were identified as high-risk populations. • Higher socio-demographic index regions were identified as high-risk areas. • The disease burden attributable to osteoarthritis knee increased from 1990 to 2019. • The number of deaths and DALYs cases would still increase in the next 25 years.</p>","PeriodicalId":10482,"journal":{"name":"Clinical Rheumatology","volume":" ","pages":"1769-1810"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11993502/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10067-025-07347-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Osteoarthritis knee poses a substantial and pervasive global health challenge.

Methods: The data was extracted from the Global Burden of Disease 2021 Study database. First, numbers and age-standardized rates (ASRs) of incidence, prevalence, and disability-adjusted life years (DALYs) of osteoarthritis knee were assessed globally and by sub-types in 2021. Subsequently, we employed a linear regression model to analyze the temporal trends from 1990 to 2021. To predict the future burden, we utilized the age-period-cohort model and the Bayesian age-period-cohort model. Furthermore, we conducted a sensitivity analysis using the Autoregressive Integrated Moving Average model and the Exponential Smoothing model.

Results: In 2021, osteoarthritis knee accounted for 30.85 million incidence cases, 374.74 million prevalence cases, and 12.02 million DALYs cases globally, with ASRs of 353.67, 4294.27, and 137.59, respectively. Females and individuals over 50 years old were identified as high-risk populations, while higher socio-demographic index regions emerged as high-risk areas. From 1990 to 2021, incidence cases rose from 14.13 million to 30.85 million, prevalence cases from 159.80 million to 374.74 million, and DALYs cases from 5.15 million to 12.02 million, accompanied by increases in their respective ASRs. Projections using the APC model predict a continued increase in incidence, prevalence, and DALYs cases for both genders until 2046. Specifically, male incidence cases are projected to increase to 18.45 million and female incidence to 25.60 million. Similarly, male prevalence cases are projected to rise to 235.41 million and female prevalence to 365.97 million. Male DALYs cases are expected to increase to 7.52 million and female DALYs to 11.55 million. The BAPC models also indicate an upward trend in number of cases.

Conclusion: In conclusion, osteoarthritis knee represents a formidable threat to global public health, necessitating the development of proactive and tailored strategic interventions that account for global-specific contexts. Key Points • Females and individuals over 50 years old were identified as high-risk populations. • Higher socio-demographic index regions were identified as high-risk areas. • The disease burden attributable to osteoarthritis knee increased from 1990 to 2019. • The number of deaths and DALYs cases would still increase in the next 25 years.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
膝骨关节炎的全球负担:一项基于人群的研究的二次数据分析。
背景:膝骨关节炎是一项重大而普遍的全球健康挑战。方法:数据从全球疾病负担2021研究数据库中提取。首先,在2021年全球范围内按亚型评估骨关节炎的发病率、患病率和残疾调整生命年(DALYs)的数量和年龄标准化率(ASRs)。随后,我们采用线性回归模型分析了1990 - 2021年的时间趋势。为了预测未来的负担,我们使用了年龄-时期-队列模型和贝叶斯年龄-时期-队列模型。此外,我们使用自回归综合移动平均模型和指数平滑模型进行了敏感性分析。结果:2021年,全球骨关节炎膝关节发病率3085万例,患病率37474万例,DALYs 1202万例,asr分别为353.67、4294.27、137.59。女性和50岁以上的人被确定为高危人群,而社会人口指数较高的地区被确定为高风险地区。从1990年到2021年,发病率从1413万例增加到3085万例,患病率从1.598亿例增加到3.774亿例,DALYs病例从515万例增加到1202万例,同时各自的asr也有所增加。使用APC模型的预测预测,到2046年,男女的发病率、患病率和DALYs病例将继续增加。具体来说,预计男性发病率将增加到1845万,女性发病率将增加到2560万。同样,预计男性患病率将上升至2.3541亿,女性患病率将上升至3.6597亿。预计男性伤残调整生命年病例将增加到752万例,女性伤残调整生命年病例将增加到1155万例。BAPC模型还表明,病例数呈上升趋势。结论:总之,膝骨关节炎对全球公共卫生构成了巨大威胁,因此有必要根据全球具体情况制定积极主动、量身定制的战略干预措施。•女性和50岁以上的个人被确定为高危人群。•社会人口指数较高的地区被确定为高风险地区。•从1990年到2019年,归因于膝骨关节炎的疾病负担有所增加。•今后25年,死亡人数和残疾调整生命年病例数仍将增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Rheumatology
Clinical Rheumatology 医学-风湿病学
CiteScore
6.90
自引率
2.90%
发文量
441
审稿时长
3 months
期刊介绍: Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level. The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.
期刊最新文献
Correction: Test the reliability and comparability of the paper version and electronic version of the Western Ontario and McMaster University Osteoarthritis Index in Chinese language: a randomized, cross-sectional study. IL-33/ST2 induces Tfh cells activation and GCs formation in collagen-induced arthritis. Short-term efficacy and safety of sublingual cyclobenzaprine for fibromyalgia: A systematic review and meta-analysis. Diagnostic accuracy and psychometric properties of the fibromyalgia rapid screening tool in Mexican patients with chronic musculoskeletal pain. UK Medical Cannabis Registry: a case series analysing clinical outcomes of medicinal cannabis therapy for fibromyalgia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1